On December 2, 2004, Moriya, Minoru; Suzuki, Takao; Ishihara, Akane; Iwaasa, Hisashi; Kanatani, Akio published a patent.Recommanded Product: 5-Phenylpyrimidine-2-carboxylic acid The title of the patent was Preparation of pyrimidine derivatives having 2-aminoquinoline moiety as MCH receptor antagonists. And the patent contained the following:
Title compounds I [R1, R2 = alkyl, etc.; R3, R4, R6, R7 = H, alkyl, etc.; R5 = H, alkyl; R8 = halo, etc.; n = 0-4] were prepared For example, hydrogenation of nitro compound (R)-II followed by acylation with 5-phenylpyrimidine-2-carboxylic acid afforded compound (R)-III. In MCH (melanin concentrating hormone) binding assays, the IC50 value of compound (R)-III was 4.1 nM. Compounds I are claimed useful for the treatment of obesity, diabetes, etc. The experimental process involved the reaction of 5-Phenylpyrimidine-2-carboxylic acid(cas: 85386-20-5).Recommanded Product: 5-Phenylpyrimidine-2-carboxylic acid
The Article related to aminoquinoline preparation mch melanin concentrating hormone receptor antagonist, antiobesity aminoquinoline preparation mch melanin concentrating hormone receptor antagonist, antidiabetic agent aminoquinoline preparation mch receptor antagonist and other aspects.Recommanded Product: 5-Phenylpyrimidine-2-carboxylic acid
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia